PBS Biotech

PBS Biotech aims to be the leading provider of innovative, single-use bioreactor systems specifically designed to address the unique challenges of cultivating shear sensitive cell types for cell therapy development. Our offering includes scalable, cost-effective disposable solutions designed to take you from benchtop R&D to large-scale cGMP manufacturing, and expert process development services to help solve cell culture challenges and accelerate your path to commercialization. To learn more, contact our sales team at sales@pbsbiotech.com or visit our website at www.pbsbiotech.com

Disposable bioreactors,bioprocess solutions,lab to cgmp cell culture development,usp class vi plastics,cell therapy solutions,process development services,cgmp,ipscs,mscs,pluripotent stem cells,mesenchymal stem cells,stem cells,scale-up,3d cell culture,single-use bioreactors,subs,and process development

Pbs biotech operates in the Biotechnology research industry.

Pbs biotech's revenue is 11m - 100m

Pbs biotech has 51 - 200 employees.